Centro di Riferimento Oncologico IRCCS

Aviano 33081

2 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Renal Cell, Locally Advanced or Unresectable Metastatic Breast Cancer, Metastatic Urothelial Cancer, NSCLC, Stage IV Breast Cancer

Studies at this site

• A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies — Recruiting now
• Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed